Daniel Petrylak
Associate Program Director · Yale-New Haven Hospital
Credentials: · · · ·
History
- Present
- Present
Genitourinary Oncology Division · Yale-New Haven Hospital
- Present
Genitourinary Oncology Division · Yale Cancer Center
1985–1986- 1985–1986
Bronx Municipal Hospital
Research
New England Journal of Medicine · 2004 · First of 14 authors · 3,019 citations
The Lancet · 2016 · 2,972 citations
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
New England Journal of Medicine · 2017 · 2,802 citations
38 papers
35 papers
33 papers
- JR
28 papers
27 papers
- NS
27 papers
- CH
26 papers
26 papers
Grants
- 1997–2024
- 1995–2003
Columbia University Southwest Oncology Group Program
National Cancer Institute · U10
Contact PI · $46K · Columbia University Health Sciences
- 1997–1999
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $131.2K · Columbia University Health Sciences
Clinical trials
- 2011–2014
Principal investigator · Completed · Phase 2
Achieve Life Sciences
- 2006–2010
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
Principal investigator · Terminated · Phase 1, Phase 2
Columbia University
- 2004–2006
S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Study chair · Terminated · Phase 2
SWOG Cancer Research Network
- 2001–2007
S0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary Tract
Study chair · Completed · Phase 2
SWOG Cancer Research Network